Treatments for Erectile Dysfunction (ED) using EDSWT (Erectile Dysfunction Shock Wave Therapy)
The prevalence of Erectile Dysfunction (ED or what is mistakenly called “impotence” is estimated to affect 10% of the adult male population; chronic ED may affect 50% of men between the ages of 40 to 70, and transient loss or inadequate erection affects men of all ages.
The current available treatment options comprised of surgery (use of implants, reconstruct arteries or block-off veins), vacuum constrictions devices, hormonal therapy and pharmacotherapy.
The majority of treatments and management performed today on patients with Erectile Dysfunction is done by modalities that relay mainly on the usage of pharmacotherapy particularly PDE-5 inhibition medication (Viagra / Cialis / Levitra).
Although there is no doubt on the impact that PDE-5 inhibition medication has on the field of sexual medicine, there is a growing realization that pharmacotherapy is not sufficient, especially in such delicate and complex matter as the male sexuality.
When it comes to the male sexuality, we have to attribute physiological as well as emotional factors that concern the treatments of ED and have not been solved by PDE-5 inhibitors, such as spontaneity in sexual intercourse and mainly the self-esteem that is damaged by the dependency on medication in order to be able to have sexual intercourse.
A new, non-invasive therapy which implements the ability of low-intensity shock waves to induce local and controlled angiogenesis and development of collaterals is becoming a new alternative in the treatment of patients with ED. This therapy can offer a true and complete solution to patients that suffer from vascular related ED problems.
Low Intensity Shock Wave Therapy (EDSWT) was officially accepted by the European Association of Urology (EAU) as the gold standard for treatment of Erectile Dysfunction in the EAU 2013 Guidelines on Male Sexual Dysfunction.
This was based on clinical trials using the Medispec’s ED1000.